| Literature DB >> 29848939 |
Serhat Uysal1, Anil Murat Ozturk, Meltem Tasbakan, Ilgin Yildirim Simsir, Aysegul Unver, Nevin Turgay, Husnu Pullukcu.
Abstract
BACKGROUND: Myiasis complication of diabetic foot ulcer has only been presented in a few case reports. Therefore, there is a need for additional data on this infestation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29848939 PMCID: PMC6074300 DOI: 10.5144/0256-4947.2018.208
Source DB: PubMed Journal: Ann Saudi Med ISSN: 0256-4947 Impact factor: 1.526
Figure 1Larvae were collected with a sterile surgical tweezers.
Figure 2Larvae were identified macro- and microscopically.
Demographic and clinical features of the cases.
| No | Age (years) | Gender | DM duration (years) | Wound duration (days) | Necrosis | Sepsis | PEDIS-IDSA infection score | Addition diseases | Confined to bed | Living in nursing home | Homeless or living alone | Poor hygienic conditions | Bacterial growth in tissue culture | Date of infestation (month) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||
| 1 | 87 | Female | 30 | 15 | Yes | Yes | Severe | Alzheimer | Yes | Yes | No | Yes | August 2014 | |
| 2 | 64 | Female | 13 | 60 | No | Yes | Severe | CVE | Yes | No | No | Yes | June 2013 | |
| 3 | 67 | Male | 12 | 40 | Yes | Yes | Severe | CRF, HT | No | No | No | Yes | February 2013 | |
| 4 | 74 | Male | 25 | 180 | No | No | Moderate | – | No | No | No | Yes | Negative | July 2013 |
| 5 | 48 | Male | 15 | 180 | Yes | No | Moderate | CRF, HT | No | No | Yes | No | Negative | June 2013 |
| 6 | 83 | Female | 27 | 30 | Yes | Yes | Severe | HT, Alzheimer | No | Yes | No | No | March 2016 | |
| 7 | 62 | Male | 10 | 150 | No | No | Moderate | RA, HT, CVE, PAD | No | No | No | Yes | May 2017 | |
| 8 | 78 | Male | 11 | 30 | Yes | Yes | Severe | HT, CHF, CVE | Yes | Yes | No | Yes | May 2017 | |
| 9 | 82 | Female | 20 | 12 | Yes | No | Mild | HT | No | No | No | Yes | Negative | May 2017 |
| 10 | 64 | Female | 14 | 7 | Yes | Yes | Severe | HT | No | No | No | Yes | July 2016 | |
| 11 | 77 | Female | 25 | 60 | Yes | Yes | Severe | HT | No | No | No | Yes | May 2017 | |
| 12 | 63 | Male | 12 | 85 | Yes | No | Moderate | PAD, HT | No | No | No | Yes | Negative | May 2017 |
| 13 | 59 | Male | 10 | 20 | Yes | Yes | Severe | CAD | No | No | Yes | Yes | Negative | May 2017 |
| 14 | 70 | Female | 10 | 30 | Yes | No | Moderate | CAD, PAD | No | No | Yes | Yes | June 2017 | |
| 15 | 66 | Male | 15 | 40 | Yes | No | Mild | – | No | No | No | Yes | Negative | June 2017 |
| 16 | 74 | Male | 27 | 80 | Yes | No | Moderate | HT, CAD, PAD | No | No | No | Yes | June 2017 | |
| 17 | 64 | Female | 4 | 30 | Yes | Yes | Severe | CRF, HT, Cataract | No | No | Yes | Yes | July 2017 | |
| 18 | 53 | Male | 10 | 15 | Yes | Yes | Severe | CRF, PAD, HT | No | No | Yes | Yes | Negative | July 2017 |
CAD, coronary artery disease; CRF, chronic renal failure; CVE, central vascular event; DM, diabetes mellitus; ESBL, extended-spectrum beta lactamase; HT, hypertension; IDSA, Infectious Diseases Society of America score; PEDIS, Perfusion, Extent, Depth, Infection And Sensation Score; RA, rheumatoid arthritis; PAD, peripheral artery disease.